Bausch Health Companies GAAP EPS of $0.48 beats by $0.10, revenue of $2.68B beats by $50M
Source: SeekingAlpha
2025-10-29 16:37:19 ET
More on Bausch Health Companies
- Bausch Health: Repricing Continues As Deleveraging Gains Traction
- Why Bausch Health Stock Surged By Nearly 20%
- Bausch Health Companies Q3 2025 Earnings Preview
- Bausch, Teva face lawsuit for delay in generic version of Xifaxan
- Seeking Alpha’s Quant Rating on Bausch Health Companies
Read the full article on Seeking Alpha
For further details see:
Bausch Health Companies GAAP EPS of $0.48 beats by $0.10, revenue of $2.68B beats by $50M
Bausch Health Companies Inc.
NASDAQ: BHC:CC
BHC:CC Trading
-0.34% G/L:
$5.88 Last:
1,784,767 Volume:
$5.90 Open:
BHC:CC Latest News
February 23, 2026 08:00:00 am
Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada
February 19, 2026 08:00:00 am
Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) Microspheres
